Genetic Test Results and Disclosure to Family Members: Qualitative Interviews of Healthcare Professionals' Perceptions of Ethical and Professional Issues in France
Overview
Affiliations
The benefit of disclosing test results to next of kin is to improve prognosis and-in some cases-even prevent death though earlier monitoring or preventive therapies. Research on this subject has explored the question of intra-familial communication from the standpoint of patients and relatives but rarely, from the standpoint of healthcare professionals. The purpose of this study was to interview relevant healthcare professionals in France, where legislation framing the issue was recently passed. A qualitative study consisting of semi-structured interviews was set up to get a clearer picture of the challenges arising from this issue, its consequences in terms of medical care-service practices, and the positions that frontline professionals have taken in response to this new legal framework. The findings from eight interviews with 7 clinical geneticists and 1 genetic counselor highlight very different patterns of practices among care services and among the genetic diseases involved. It is equally crucial to investigate other issues such as the nature of genetic testing and its consequences in terms of disclosing results to kin, the question of the role of genetic counseling in the disclosure process, the question of prescription by non-geneticist clinicians, and practical questions linked to information content, consent and medical follow-up for patients and their relatives.
Clinician perspectives on policy approaches to genetic risk disclosure in families.
Phillips A, Vears D, Van Hoyweghen I, Borry P Fam Cancer. 2024; 23(2):177-186.
PMID: 38548926 PMC: 11233314. DOI: 10.1007/s10689-024-00375-2.
Disclosure of genetic information to family members: a systematic review of normative documents.
Phillips A, Borry P, Van Hoyweghen I, Vears D Genet Med. 2021; 23(11):2038-2046.
PMID: 34234303 DOI: 10.1038/s41436-021-01248-0.
Patient and Family Preferences on Health System-Led Direct Contact for Cascade Screening.
Henrikson N, Blasi P, Figueroa Gray M, Tiffany B, Scrol A, Ralston J J Pers Med. 2021; 11(6).
PMID: 34200550 PMC: 8230217. DOI: 10.3390/jpm11060538.
How do non-geneticist physicians deal with genetic tests? A qualitative analysis.
Pasquier L, Minguet G, Moisdon-Chataigner S, Jarno P, Denizeau P, Volf G Eur J Hum Genet. 2021; 30(3):320-331.
PMID: 33907318 PMC: 8904857. DOI: 10.1038/s41431-021-00884-z.
Sharing genetic test results with family members of BRCA, PALB2, CHEK2, and ATM carriers.
Dean M, Tezak A, Johnson S, Pierce J, Weidner A, Clouse K Patient Educ Couns. 2021; 104(4):720-725.
PMID: 33455826 PMC: 8005459. DOI: 10.1016/j.pec.2020.12.019.